7CA8
The crystal structure of COVID-19 main protease in complex with an inhibitor Shikonin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U1 |
Synchrotron site | SSRF |
Beamline | BL17U1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2020-05-29 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.97913 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 67.960, 102.370, 103.540 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 56.810 - 2.450 |
R-factor | 0.233134579919 |
Rwork | 0.230 |
R-free | 0.27886 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7c2q |
RMSD bond length | 0.008 |
RMSD bond angle | 1.019 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHENIX |
Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 56.815 | 2.510 |
High resolution limit [Å] | 2.450 | 2.450 |
Rmerge | 0.128 | 1.568 |
Number of reflections | 27221 | 2015 |
<I/σ(I)> | 15.7 | |
Completeness [%] | 99.7 | |
Redundancy | 13.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | 0.1M HEPES 7.5, 20% PEG 10000 |